16:57:52 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Valeo Pharma Inc
Symbol VPH
Shares Issued 98,666,855
Close 2024-03-06 C$ 0.195
Market Cap C$ 19,240,037
Recent Sedar Documents

Valeo Pharma to release Q1 2024 results March 14

2024-03-07 09:25 ET - News Release

Mr. Steve Saviuk reports

VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL/WEBCAST

Valeo Pharma Inc. will release its financial results and highlights for the first quarter ended Jan. 31, 2024, on Thursday, March 14, 2024, after market close. The company will host a conference call to discuss those results and highlights on Friday, March 15, 2024, at 8:30 a.m. ET.

To join the conference call without operator assistance, you may register to receive an instant, automated callback. You can also dial direct to be entered into the call by an operator.

Conference call details

Conference ID:  66767002

Date:  Friday, March 15, 2024

Time:  8:30 a.m. ET

Dial-in numbers:  1-888-664-6392 or 416-764-8659

Audio replay numbers:  1-888-390-0541 or 416-764-8677

Replay code:  767002 followed by the pound key

A live audio webcast of the conference call will be available.

About Valeo Pharma Inc.

Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada, with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Headquartered in Kirkland, Que., Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.